Quidel reported $68.1M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Agilent USD 282.22M 478K Mar/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Bruker USD 152.22M 282K Mar/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Danaher USD 702.9M 4.8M Jun/2026
Haemonetics USD 45.47M 1.36M Jun/2026
Illumina USD 151.3M 607K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Merit Medical Systems USD 59.71M 55K Jun/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Neogen USD 217.7M 27K Mar/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quidel USD 68.1M 200K Mar/2026
Revvity USD 111.63M 174K Jun/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Waters USD 98.19M 20K Jun/2026